U.S. Marketed Products
This information is intended for U.S. healthcare professionals only.
In the United States, we have the following three marketed products that span two areas:
- ANGIOMAX® (bivalirudin) for Injection in acute cardiovascular care; and
- ORBACTIV® (oritavancin) for Injection and MINOCIN® (minocycline) for Injection in infectious disease care
Please see the full prescribing information and Important Safety Information for these products below.
Global Medical Information
The Global Health Science Center (GHSC) Medical Professionals are available to answer your medical information requests, or receive adverse event reports, other safety related information, and product complaints.
Please click below to contact the Global Health Science Center.
Alternatively, adverse events may be reported to the FDA MedWatch Reporting System by phone at 1 800 FDA 1088 (1 800 332 1088) or by mail using Form FDA 3500 at www.fda.gov/medwatch